What We're Reading: Page 373
Industry reads hand-picked by our editors
Jan 22, 2015
-
Medium
Obama proposes genetic 'Precision Medicine Initiative' at State of the Union
-
4 key industry trends that will impact biopharma in 2015
-
India issues draft bioequivalence request format for drugs aimed for export
-
UPDATE: Pfizer gives poor nations modest discount after vax price blowback
-
-
J&J's Q4 earnings: A solid 2014
-
-
-
Ambitious RNA biotech Alnylam raising $450M, looking for acquisitions
-
Jan 21, 2015
-
One more push: Senators reintroduce bill to expedite antibiotic approval
-
China FDA to reverse course, allow online Rx drug sales
-
-
Hospira closes North Carolina plant over cost concerns
-
-
AbbVie strikes hep C discount deal with US state-based AIDS programs
-
UPDATED: Yet another major insurance company strikes hep C deal with Gilead
-
-
-
Jan 20, 2015
-
-
Blast from the past: Roche's dalcetrapib, HDL-raising meds could work for some patients
-
Pfizer warns UK MDs: Lyrica is still on patent for pain
-
Flu vaccine only 23% effective this season
-
-
J&J: Women were inappropriately pressured to file pelvic mesh suits
-
-
Pharma stocks plunge as Switzerland discontinues fixed-price peg to euro
-
-
Jan 16, 2015
-
-
AbbVie's Humira/hep C plans, bluebird bio, NIH funding, and even more from JPM15
-
-
Intrexon, Ziopharma invest $100M in MD Anderson cancer immunotherapy tech
-
-
-
Johnson & Johnson to release trial data
-
New Brilinta data supports extending use beyond one year
-
-
FDA approves novel weight-loss device
Previous
